PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 39 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $78,000 | +9.9% | 40,000 | 0.0% | 0.02% | +7.1% |
| Q1 2015 | $71,000 | -4.1% | 40,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $74,000 | -23.7% | 40,000 | 0.0% | 0.01% | -30.0% |
| Q3 2014 | $97,000 | -33.6% | 40,000 | 0.0% | 0.02% | -31.0% |
| Q2 2014 | $146,000 | -20.2% | 40,000 | 0.0% | 0.03% | -23.7% |
| Q1 2014 | $183,000 | – | 40,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zhang Financial LLC | 45,000 | $36,000 | 0.02% |
| A.R.T. Advisors, LLC | 381,955 | $319,000 | 0.02% |
| Virtu KCG Holdings LLC | 705,907 | $591,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 687,796 | $576,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 89,813 | $73,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,945,682 | $1,630,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $272,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $253,000 | 0.00% |
| WEDBUSH SECURITIES INC | 23,000 | $19,000 | 0.00% |
| Renaissance Technologies | 2,300,800 | $1,927,000 | 0.00% |